Person entering Gilead building Leading the pack is Gilead Sciences' HIV medication Biktarvy, which had U.S. sales revenue five times greater than the rest of the world. (Photo: David Paul Morris/Bloomberg)

Americans spent nearly twice as much on the 20 top-selling pharmaceuticals as the rest of the world combined last year, according to an analysis by the interest group Public Citizen.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.